三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效
图片属性
图片格式：PNG 图片大小：348KB 图片尺寸：2304*979
同报告图片
 / 4
AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效_第1页
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
AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效_第2页
fCDlk4HniYwgICAgICAgfCDljaDmr5QgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS18CnwgQkFJIFpFIEFOICB8IDM1JSAgfAp8IFRZVllUICAgICAgfCAyNSUgIHwKfCBBTCBSVUkgS0EgIHwgMTUlICB8CnwgS0VZVFJVREEgICB8IDEwJSAgfAp8IFRVTyBZSSAgICAgfCA1JSAgIHwKfCBIQU4gU0hJIFpIVUFORyB8IDMlICB8CnwgVEVDRU5UUklRICB8IDIlICAgfAp8IE9QRElWTyAgICAgfCAyJSAgIHwKfCBBTiBOSSBLRSAgIHwgMSUgICB8CnwgRU4gV0VJIERBICB8IDElICAgfAp8IE9USEVSUyAgICAgfCAxJSAgIHwKCui1hOaWmeadpea6kO+8mklRVklB77yM5Lit5rOw6K+B5Yi456CU56m25omA
AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效_第3页
AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效_第4页
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
AK104治疗末线宫颈癌对比PD-1单药或PD-1+CTLA4联合疗法明显提升疗效_第5页
所属报告： 康方生物-港股公司研究报告-双特异抗体龙头国际化之路现胜利曙光-240621（37页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询商务合作事宜
copyright@2008-2013 长沙思想领动信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备2023027541号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠